These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3138905)

  • 1. Flecainide for supraventricular and ventricular arrhythmias in children and young adults.
    Zeigler V; Gillette PC; Ross BA; Ewing L
    Am J Cardiol; 1988 Oct; 62(10 Pt 1):818-20. PubMed ID: 3138905
    [No Abstract]   [Full Text] [Related]  

  • 2. Flecainide toxicity in a neonate with supraventricular tachycardia.
    Zeigler VL; Peterson J
    Heart Lung; 1991 Nov; 20(6):689-91. PubMed ID: 1960074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
    Musto B; D'Onofrio A; Cavallaro C; Musto A; Della Gatta O; Marsico F
    G Ital Cardiol; 1987 May; 17(5):444-9. PubMed ID: 3115857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of refractory supraventricular arrhythmias with flecainide acetate.
    Till JA; Rowland E; Shinebourne EA; Ward DE
    Arch Dis Child; 1987 Mar; 62(3):247-52. PubMed ID: 3105471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New antiarrhythmic drugs. II. Flecainide.
    Schneeweiss A
    Pediatr Cardiol; 1990 Jul; 11(3):143-6. PubMed ID: 2118629
    [No Abstract]   [Full Text] [Related]  

  • 6. Flecainide acetate for resistant arrhythmias in the young: efficacy and pharmacokinetics.
    Perry JC; McQuinn RL; Smith RT; Gothing C; Fredell P; Garson A
    J Am Coll Cardiol; 1989 Jul; 14(1):185-91; discussion 192-3. PubMed ID: 2500470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with flecainide for symptomatic and refractory tachyarrhythmias in children.
    Ismail Z; Alwi M; Lim MK; Murtazam HA; Jamaluddin A
    Acta Paediatr Jpn; 1994 Feb; 36(1):44-8. PubMed ID: 8165907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal and maternal magnetocardiography during flecainide therapy for supraventricular tachycardia.
    Campbell JQ; Best TH; Eswaran H; Lowery CL
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):767-71. PubMed ID: 17018496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tachycardias: considerations in childhood in the 90s].
    Gutiérrez-Larraya F; Jabón A
    An Esp Pediatr; 1993 Dec; 39(6):475-88. PubMed ID: 8166400
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of flecainide in children.
    Till JA; Rowland E; Shinebourne EA
    Lancet; 1989 Aug; 2(8658):326. PubMed ID: 2569119
    [No Abstract]   [Full Text] [Related]  

  • 11. [Our experience with flecainide acetate in resistant arrhythmias in children. Apropos of 35 cases].
    Denjoy I; Lucet V; Do Ngoc D; Magnier S; Casasoprana A; Coumel P
    Arch Mal Coeur Vaiss; 1991 May; 84(5):647-52. PubMed ID: 1910326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of intravenous flecainide acetate in patients with concealed atrioventricular pathway with supraventricular tachycardia].
    Song Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):361-3, 397. PubMed ID: 1821351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flecainide acetate in the treatment of resistant supraventricular arrhythmias.
    Epstein M; Jardine RM; Obel IW
    S Afr Med J; 1988 Dec; 74(11):559-62. PubMed ID: 3143159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Flecainide and anti-arrhythmia therapy].
    Croce L; Romano S; Pozzoni L; Lomuscio A
    Minerva Med; 1988 Mar; 79(3):229-34. PubMed ID: 3129677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
    Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of a "bystander" concealed accessory pathway in the response to verapamil and flecainide treatment in a patient with nodal reentry tachycardia].
    Matteucci C; Busi G
    G Ital Cardiol; 1996 Apr; 26(4):419-25. PubMed ID: 8707026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ
    Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment.
    Uzun O; Babaoglu K; Sinha A; Massias S; Beattie B
    Cardiol Young; 2012 Aug; 22(4):372-80. PubMed ID: 22008551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.